CRY2 (cryptochrome circadian regulator 2) serves as a core transcriptional repressor in the molecular circadian clock mechanism. CRY2 functions within the negative feedback loop of the transcription-translation feedback loop (TTFL), where it interacts with CLOCK-BMAL1 heterodimers to inhibit their transcriptional activity and negatively regulate its own expression 1. While CRY2 has redundant functions with CRY1, it exhibits distinct characteristics in circadian regulation, showing less potent transcriptional repression in cerebellum and liver compared to CRY1, and being less effective in lengthening the SCN oscillator period 2. CRY2 knockout cells display long-period rhythms, contrasting with the short-period phenotype of CRY1 knockouts 2. Beyond circadian regulation, CRY2 demonstrates tumor suppressor properties in osteosarcoma, where its knockdown promotes cell proliferation and migration through MAPK and Wnt/β-catenin signaling pathways 3. CRY2 expression correlates with human navigation abilities, potentially through modulation of circadian rhythm 4. Additionally, CRY2 gene methylation appears to moderate the relationship between insomnia symptoms and mental health outcomes in a sex-specific manner 5. Altered CRY2 expression is associated with mood disorders, showing decreased levels in bipolar depression patients 6.